Metformin hydrochloride improves hepatic glucolipid metabolism in diabetes progression through SIRT5-mediated ECHA desuccinylation
Abstract The management of hyperglycemia and lipid metabolism is pivotal for the treatment of type 2 diabetes mellitus (T2DM). Metformin hydrochloride (DMBG) remains the most widely prescribed medication for this condition. This study aimed to elucidate the effects and underlying mechanisms by which...
Saved in:
| Main Authors: | Liang Tang, Qing Sun, Jinling Luo, Suying Peng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-03-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-92716-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SIRT5 inhibits glycolysis and nasal type extranodal NK/T cell lymphoma cell proliferation by catalyzing the desuccinylation of glucose-6-phosphate isomerase
by: Tiansheng Wang, et al.
Published: (2025-01-01) -
SIRT5‐mediated HOXA5 desuccinylation inhibits ferroptosis to alleviate sepsis induced‐lung injury
by: Lei Wang, et al.
Published: (2025-01-01) -
Metformin hydrochloride laden nanostructured lipid carriers: A promising strategy for skin diseases
by: Reem Y. Mahran, et al.
Published: (2025-01-01) -
Role of Environmental Photocatalysts and Organic Matter on the Degradation and Toxicity of Metformin Hydrochloride
by: Rifat Khan, et al.
Published: (2025-05-01) -
HPLC and HPTLC methods for simultaneous quantification of Metformin hydrochloride, Vildagliptin and Dapagliflozin propanediol with comparative evaluation by greenness and whiteness assessment tools
by: Krinal Barot, et al.
Published: (2025-06-01)